These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 37463165)
1. Podocytopathies related to either COVID-19 infection or its vaccination, our experience and literature review. Pokharel A; Anderson JD; Deebajah M; Blatt NB; Reddy G; Garlapaty V; Li W; Kanaan HD; Zhang PL Ultrastruct Pathol; 2023 Sep; 47(5):373-381. PubMed ID: 37463165 [TBL] [Abstract][Full Text] [Related]
2. Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases. Gupta RK; Bhargava R; Shaukat AA; Albert E; Leggat J BMC Nephrol; 2020 Aug; 21(1):326. PubMed ID: 32753052 [TBL] [Abstract][Full Text] [Related]
3. Longitudinal Outcomes of COVID-19-Associated Collapsing Glomerulopathy and Other Podocytopathies. Kudose S; Santoriello D; Bomback AS; Sekulic M; Batal I; Stokes MB; Ghavami IA; Kim JS; Marasa M; Xu K; Peleg Y; Barasch J; Canetta P; Rasouly HM; Gharavi AG; Markowitz GS; D'Agati VD J Am Soc Nephrol; 2021 Nov; 32(11):2958-2969. PubMed ID: 34670811 [TBL] [Abstract][Full Text] [Related]
4. Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review. Teragaki M; Tanaka M; Yamamoto H; Watanabe T; Takeoka J; Fukumi A; Maeda K; Takami Y; Saita H; Iwanari S; Ikeda M; Takeoka H CEN Case Rep; 2024 Feb; 13(1):53-58. PubMed ID: 37244881 [TBL] [Abstract][Full Text] [Related]
5. An Update on Viral Infection-Associated Collapsing Glomerulopathy. Fisher M; Ross M; DiFranza L; Reidy K Adv Kidney Dis Health; 2024 Jul; 31(4):317-325. PubMed ID: 39084757 [TBL] [Abstract][Full Text] [Related]
6. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. Lebedev L; Sapojnikov M; Wechsler A; Varadi-Levi R; Zamir D; Tobar A; Levin-Iaina N; Fytlovich S; Yagil Y Am J Kidney Dis; 2021 Jul; 78(1):142-145. PubMed ID: 33839200 [TBL] [Abstract][Full Text] [Related]
7. Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020. Ahn W; Bomback AS Am J Kidney Dis; 2020 Jun; 75(6):955-964. PubMed ID: 32331832 [TBL] [Abstract][Full Text] [Related]
8. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report. Leclerc S; Royal V; Lamarche C; Laurin LP Am J Kidney Dis; 2021 Oct; 78(4):607-610. PubMed ID: 34242687 [TBL] [Abstract][Full Text] [Related]
9. Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation? Annicchiarico Petruzzelli L; Minale B; Serio V; De Luca A; Marino Marsilia G; Campione S; Diomedi Camassei F; D'Arcangelo R; Luongo I; Lepore L; Giannattasio P; Molino D; Pirro L; Lonardo MC; Malgieri G; Pecoraro C G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655832 [TBL] [Abstract][Full Text] [Related]
12. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease. da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279 [TBL] [Abstract][Full Text] [Related]
13. Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria. Akilesh S; Nast CC; Yamashita M; Henriksen K; Charu V; Troxell ML; Kambham N; Bracamonte E; Houghton D; Ahmed NI; Chong CC; Thajudeen B; Rehman S; Khoury F; Zuckerman JE; Gitomer J; Raguram PC; Mujeeb S; Schwarze U; Shannon MB; De Castro I; Alpers CE; Najafian B; Nicosia RF; Andeen NK; Smith KD Am J Kidney Dis; 2021 Jan; 77(1):82-93.e1. PubMed ID: 33045255 [TBL] [Abstract][Full Text] [Related]
14. COVID-19-Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis. Magoon S; Bichu P; Malhotra V; Alhashimi F; Hu Y; Khanna S; Berhanu K Kidney Med; 2020; 2(4):488-492. PubMed ID: 32775989 [TBL] [Abstract][Full Text] [Related]
15. Minimal change disease following the Moderna COVID-19 vaccine: first case report. Thappy S; Thalappil SR; Abbarh S; Al-Mashdali A; Akhtar M; Alkadi MM BMC Nephrol; 2021 Nov; 22(1):376. PubMed ID: 34763669 [TBL] [Abstract][Full Text] [Related]
16. Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination. Pirzadeh A; Emami S; Zuckerman JE; Nobakht N Am J Case Rep; 2023 Nov; 24():e941621. PubMed ID: 37941318 [TBL] [Abstract][Full Text] [Related]
17. Focal Segmental Glomerulosclerosis (FSGS) Progressing to Collapsing Glomerulopathy in Renal Transplant Recipients With and Without COVID-19 Infection. Thorburn CA; Samarapungavan D; Kanaan HD; Cohn S; Jabbar KJ; Li W; Bedi D; Suliman ST; Patel PJ; Putchakayala K; Singh A; Zhang PL Transplant Proc; 2022; 54(6):1465-1470. PubMed ID: 35341587 [TBL] [Abstract][Full Text] [Related]
18. Kidney Biopsy Findings in Patients with SARS-CoV-2 Infection or After COVID-19 Vaccination. de Las Mercedes Noriega M; Husain-Syed F; Wulf S; Csala B; Krebs CF; Jabs WJ; Zipfel PF; Gröne HJ; Wiech T; Clin J Am Soc Nephrol; 2023 May; 18(5):613-625. PubMed ID: 36723286 [TBL] [Abstract][Full Text] [Related]
19. De novo minimal change disease associated with reversible post-transplant nephrotic syndrome. A report of five cases and review of literature. Zafarmand AA; Baranowska-Daca E; Ly PD; Tsao CC; Choi YJ; Suki WN; Truong LD Clin Transplant; 2002 Oct; 16(5):350-61. PubMed ID: 12225432 [TBL] [Abstract][Full Text] [Related]
20. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review. Lim JH; Han MH; Kim YJ; Kim MS; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH J Korean Med Sci; 2021 Aug; 36(30):e218. PubMed ID: 34342187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]